The chemopreventive agent myo inositol inhibits Akt and extracellular signal-regulated kinase in bronchial lesions from heavy smokers.
Cancer Prev Res (Phila Pa). 2009 Apr; Han W, Gills JJ, Memmott RM, Lam S, Dennis PA. Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 2088
A phase I study of myo-inositol for lung cancer chemoprevention.
Cancer Epidemiol Biomarkers Prev. 2006 Aug. Lam S, McWilliams A, LeRiche J, MacAulay C, Wattenberg L, Szabo E. Department of Respiratory Medicine, British Columbia Cancer Agency, British Columbia, Canada.
Double-blind, controlled, crossover trial of inositol versus fluvoxamine for the treatment of panic disorder.
J ClinPsychopharmacol. 2001 June. Palatnik A, Frolov K, Fux M, Benjamin J. Ministry of Health Mental Health Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheba, Israel.
Myoinositol and folic acid combination for the treatment of erectile dysfunction in type 2 diabetes men.
Eur Rev Med Pharmacol Sci. 2006 Sep-Oct. Agostini R, Rossi F, Pajalich R. First Institute of Obstetrics and Gynecology, University La Sapienza, Rome, Italy.
Effects of inositol on ovarian function and metabolic factors in women with PCOS (Ovarpolicistic): a randomized double blind placebo-controlled trial.Eur Rev Med Pharmacol Sci. 2003 Nov-Dec.
The role of myo-inositol in multiple sclerosis GB YOUNG et al.; Journal of Neurology, Neurosurgery, and Psychiatry 1986;49:265-272